If approved, Cabometyx® would be the first and only systemic therapy approved in the European Union for previously treated neuroendocrine…
Approval based on pivotal results showing improvements in sustained disease remission and reductions in itch and oral corticosteroid use compared…
Dupixent approved in the US as the only targeted medicine to treat patients with bullous pemphigoid Approval based on pivotal…
MELBOURNE, Australia and INDIANAPOLIS, June 20, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”, “the Company”)…
Reinforcing Abu Dhabi's position as a global life science hub ABU DHABI, UAE, June 19, 2025 /PRNewswire/ -- During BIO…
GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body positron emission tomography/computed tomography (PET/CT)…
GE HealthCare and the Department of Radiology at Stanford Medicine aim to explore total body positron emission tomography/computed tomography (PET/CT)…
Powering the $600B+ Patient-Led Healthcare Revolution DENVER, June 19, 2025 /PRNewswire/ -- NeuralCure AI today announced the official launch of its…
Alpha-emitting radioisotope expected to play an essential role in next-generation targeted cancer therapiesDURHAM, N.C. and WEST VALLEY CITY, Utah, June…
crazybulk CrazyBulk New York City, NY, June 19, 2025 (GLOBE NEWSWIRE) -- As traditional anabolic steroids fall further out of…